Table 2 Baseline characteristics of syringe services programs by study arm (N = 105)
|  | Control SSPs (n = 52) | OMIE SSPs (n = 53) | Total SSPs (N = 105) |
|---|---|---|---|
Census region, n (%) | |||
 West | 24 (47) | 25 (47) | 49 (47) |
 Midwest | 12 (23) | 12 (23) | 24 (23) |
 South | 13 (25) | 8 (15) | 21 (20) |
 North | 1 (2) | 8 (15) | 9 (9) |
 Puerto Rico | 2 (4) | 0 (0) | 2 (2) |
Number of staff & volunteers, median (IQR) | 7 (3.14) | 7 (4.13) | 7 (4.13) |
All staff can provide OEND, n (%) | 34 (65) | 30 (57) | 64 (61) |
Annual budget, median (IQR) | US $106,291 (24,125–240,000) | US $145,500 (29,785–384,000) | US $119,864 (25,000–300,000) |
SSP participant contactsa, mean (sd) | 1422 (1821) | 1623 (1671) | 1522 (1742) |
Naloxone doses per contacta, mean (sd) | 1.2 (1.4) | 2.2 (3.1) | 1.7 (2.5) |
Participants receiving naloxone per contact, mean (sd) | 0.46 (0.51) | 0.62 (0.91) | 0.54 (0.73) |
Priority to expand naloxone staff | 82 (22) | 85 (22) | 84 (22) |
Priority to expand naloxone leadership | 86 (18) | 84 (24) | 85 (21) |
Number of OEND best practices implemented (19 items), mean | 12.2 | 12.0 | 12.1 |
Staff training and support (6 items) | 2.5 | 2.6 | 2.5 |
Naloxone saturation and supply (4 items) | 2.8 | 2.7 | 2.8 |
Culturally appropriate service (4 items) | 2.7 | 2.5 | 2.6 |
Grounded in harm reduction (5 items) | 4.3 | 4.2 | 4.2 |
Sessions, median (IQR) |  | 10 (8–11) |  |
Hours, median (IQR) |  | 12 (8–13) |  |